A cute he~ol~ic transfusion reactions are caused by preextstmg red cell (RBC) antibodies. They are predominantly due to an unintentional but erroneous transfusion of ABO-incompatible blood followed by intravascular hemolysis; the course is often lethaI. In contrast, delayed hemolytic transfusion re actions (DHTRs) generally result from a secondary (anam nestie) immune response after previous immunization; rarely, a rapid primary response takes a similar course. Symptoms in a DHTR are mostly milder and often absent.
Increased attention is attracted to the view that severe symptoms of hemolytic transfusion reactions reflect the presence of a systemic inflammatory response syndrome (SIRS).1.2 SIRS has been described as a syndrome of host defense failure,? and it represents an exaggerated, general ized, and autodestructive immune response accompanying severe forms of sepsis, burn, trauma, and pancreatitis.! Clinical criteria defined bya consensus conference are el evated or lowered body temperature, tachycardia, respira tory failure, and leucocytosis, leukocytopenia, or an in crease in band neutrophils.? Hypotension, decreased peripheral resistance, permeability syndrome, shock, and adult respiratory distress syndrome may lead to multiple organ failure. ' In laboratory investigations of patients with SIRS,a characteristic pattern of inflammatory mediators is observed, including acute-phase pro teins; tumor necrosis ABBREVIATIONS: CRP = C-reaetive protein; DAT = direet anti globulin test; DHTR(s) = delayed hemolytic transfusion reaetion(s); FFP = fresh-frozen plasma; IL = interleukin; IL-lra = IL-l reeeptor antagonist; LDH = lactate dehydrogenase; PMN(s) = polymorphonuclear leukoeyte(s); RBC(s) = red cellts): SIRS = systemic inflammatory response syndrome; TNFa = tumor ne erosis factor-o; factor-a (TNFa); interleukin (IL-)1, IL-6, and IL-8;white cell (WBC) contents (elastase, neopterin); complement frag ments (e.g., C3a); and other substances such as arachidonic acid products. Anti -inflammatory mediators, such as IL-l 0, IL-l receptar antagonist (Il.vl ra), and soluble TNFa recep tor, are also detectable.v" In SIRS, the balance between the proinflammatory and anti-inflammatory potential seems to be disturbed.
Davenpart et aU-IO tested several in vitro models of hemolytic transfusion reactions for the release of inflamma tory mediatars. One experimental approach was to incu bate heparinized whole blood with ABO-incompatible RBCs.TNFa was released with an early peak at 2 to 4 hours, whereas IL-8 showed a continuous increase over 24 hours; furthermare, procoagulant activity was generated. Heating ofplasma destroyed the cytokine-and procoagulant-pro ducing capacity of the system; therefare, heat-labile plasma factors, such as complement, may playa role in the initiat ing process. IL-l release was not detectable. In a further experiment, anti-Dvcoated RBCs were incubated with he parinized blood. IL-6. TNFa, and IL-l were released at low levels, whereas high levels ofIL-8 and IL-lra were observed.
Few clinical data are available to date on the question ofwhether the results ofthese in vitro studies can be of sig nificance in vivo. Areport by Butler et al.!' showed that TNFa and elastase were released in anABO-incompatible transfusion. We describe here the clinical picture and labo ratoryfindings of a severe DHTR caused by anti-D.The data give evidence for the release of mediators, as is typical for SIRS, in this condition.
CASE REPORT
A 67-year-old male patient with coronary heart disease (high-grade stenosis of ramus interventricularis anteriar) and nephrolithiasis underwent bilateral percutaneous nephrolitholapaxy (nephrolithotripsy), followed by the in sertion of a kidneyfistula catheter on both sides. He devel oped prolonged macrohematuria. Five days later, the kid ney fistula catheters were removed; on the left side, arteriovenous bleeding occurred from the puncture canal, and an extended retroperitoneal hematoma was detected. The patient underwent cardiac failure of short duration because ofvolume loss. The hematoma was removed and bleeding was stopped by surgical intervention (Day 1).The next day, another surgery was necessary because of exces sive bleeding, and the spleen was removed. The blood group of the patient was 0, D-negative. Because of the shortage of blood of this type, the patient was predorni nantly transfused with group 0, D-positive RBCsafter it was ensured that the antibody screening test was negative. In the course ofDays 1 and 2, the patient received 68 RBCunits and 63 units of fresh-frozen plasma (FFP).
The patient, intubated via tracheostoma, developed septic temperatures (39.8°C) on Day 10. Approximately 8 hours later, he developed circulatory instability and a greater need for volume substitution. He was treated with catecholamines, dopamine, dobutamine, and volume re placement solution. The same day, a DHTR was diagnosed on the basis of a strongly positive direct antiglobulin test (DAT) and the presence of anti-D in the serum of the pa tient. Because ofa drop in hemoglobinoverDays 10 and 11, the patient was first transfused with 2 RBC units and 6 FFP units; thereafter, he received an exchange transfusion, ex tending over 24 hours (Day 11 to Day 12), with 27 RBCunits (0. D-negative, K-) and 21 FFP units until the DATwas nega tive (Day 12). The recurrence of a slightly positive DATwas the reason for a second exchange transfusion on Day 14 (9 RBC units and 10 FFP units within 8 hours), which, seen retrospectively. was not necessary. The following discussion of data refers to the first exchange transfusion unless stated otherwise. Starting from Day 15, the patient experienced repetitive macrohematuria. Because of excessive arterial bleedings, his left kidney was removed on Day 17. In the further course, the patient experienced repeated bleeding from the right kidney; because of obstruction ofthe kidney and the bladder by coagula, he temporarily developed postrenal failure and had to undergo dialysis. After repeated infections and bronchopneumonia, the patient was dis charged from hospital approximately 3 months after the DHTR. At that time, his kidney function was at the stage of compensated retention.
MATERIALS AND METHODS
Serologie testing was performed with column agglutination technology (BioVue, Ortho Diagnostic Systems, Raritan, NI, or Micro Typing, DiaMed Diagnostika, Bensheim, Ger many). For antibody screening, the anti-human globulin test and bromelain-treated RBCswere used. DATs that were positive with polyspecific antiglobulin reagents were fur ther investigated with monospecific anti-IgG, anti-IgM, and anti-C3d. Anti-D test reagents used were anti-CDE Frekaklon (Fresenius Diagnostik, Bad Homburg, Germany), Seraclone anti-D blend (Biotest AG, Dreieich, Gerrnany), and anti-D fast (lmmucor Med. Diagnostik, Rödermark, Germany). For antibody titrations, an anti-human globu lin tube test was used. Acid elution of the patient's RBCswas perfarmed according to the instructions of the manufac turer (Biologische Arbeitsgemeinschaft, Lieh, Germanyl; heat eluates were prepared from washed RBCs in 0.95-per cent NaCl by agitation for 10 minutes at 56°C; the superna tant was obtained after rapid centrifugation. Before and during the exchange transfusion, serum and plasma of the patient (anticoagulated with citrate or EDTA) were imme diately frozen either at -20°C for various labaratory mea surements or at -70°C for complement determinations.
The following measurements were made byenzyme linked immunosorbent assay: C3a-desArg (Pro gen Bio technik, Heidelberg, Germany); TNFa, IL-6, IL-8, and IL-I0 
RESULTS

Serologie investigations
The antibody screening test was negative with the serum of the patient at four time points ranging from 4 months before the massive transfusion to shortly before
MEDIATORS OF SIRS IN DHTR
Investigation by the column agglutination method showed the presence ofIgG on the patient's RBCs;C3d was not de tectable, and traces ofIgM were demonstrable only on Days 10 and 11, before the exchange transfusion. Further, the RBCsshowed a weakreaction with anti-CDE (NaClphase), and no reaction with several IgM-type anti-D reagents. Elu ates' obtained by either acid or heat, gave evidence of the presence of a single antibody, anti-D. When the DAT was performed before the exchange transfusion, almost all of the RBCs were trapped on top of the gel column. As the exchange progressed, the DAT, tested either with polyspecific reagents or with monospecific anti-lgG, showed a typical mixed-field agglutination with increasing predominance of unagglutinated cells.
Analysis of eell-fixed antibody by flow eytometry
Flow cytometric analysis gave evidence of the initial pres ence of73-percent RBCscoated with IgG.As a control, RBCs of a D-positive donor were incubated with a surplus of the patient's serum for 1 hour at 37°C in the presence of 10 mM EDTA; 99 percent of these RBCswere determined to be IgG positive. During the exchange transfusion, an exponential reduction of antibody-coated RBCs was observed ( Fig. 2) . At the end of the first exchange transfusion, 3.9 percent of the IgG-coated RBCs were left, which is equivalent to ap proximately 160 mL ofD-positive blood in the patient's cir culation; the corresponding value after the seco nd ex change was 0.97 percent, which is equivalent to 41 mL.The analysis showed onlythe presence ofIgG on the RBCs;IgM, the massive transfusion (Day 1). On 1O·~--------------,-----------,-500 the day of onset of clinical symptoms
ofthe DHTR (Day 10), anti-Dwas de tectable with a titer of 256, which rose to 1536 the next day, despite the transfusion of 6 FFP units. The peak was reached approximately 10 days later, and thereafter the titer fell, to less than 15 at the time the patient was discharged from hospital. In ad dition to anti-D, anti-C and anti-K ap peared on Day 12, and their peak and decline essentially followed the pro file for anti-D, although the maxi mum values were much lower ( Fig.1) . Finally, anti-E was observed, though 10 not before Day 26, reached a maxi mum titer of 2, and became unde MTi TRi tectable 3 months after the massive transfusion (not shown). 
Bilirubin (total and direct bilirubin, with little difference) increased from Total WBCs, differential, and platelet count
The WBCcount was in the low normal range after the mas IgD,and IgAwere negative. After fluorescence stainingwith sive transfusion and rose until Day 7. On Day 8, the WBC anti-K and anti-X, the RBCs showed a homogeneous peak of Kand A. double-labeling.
Clinical presentation
During the patients stay in the inten sive care unit, the APACHE II score was determined. In parallel with the DHTR, a rise in the score was ob 1.2 served, reaching a maximum 2 days o after the onset of symptoms (Fig. 2 ). nephrectomy. (Fig. 5) . Corticosteroids, which could have influenced the massive transfusion and stayed at high levels during the ob WBCcounts, were not given during the observation period.
servation period. The onset ofthe DHTR was accompanied The differential count was characterized by a peak in by a further moderate increase (Fig. 6) . A drop on Day 17 the absolute numbers of PMNs and band neutrophils in was followed by a sharp increase after nephrectomy.
---, -------------------------r 40
-o-PMNs • "Bands" • Lymphocytes relation to the DHTR and a lymphopenia developing continu ously after the massive transfusion (Fig. 5) . At Day-3, before the massive transfusion, lymphocytes were in the normal range (28%); the lympho penia after the massive transfusion was persistent; at Day 35, the relative number was still at 8 percent.
Platelets and monocytes showed a continuous recovery after the mas sive transfusion. They had fallen be fore (onlymonocytes) andduringthe exchange transfusion (monocytes and platelets, data not shown).
Acute-phase proteins
Fibrinogen levels increased after the massive transfusion, reaching a peak on Days 6 and 7 ( Fig. 6) . At the time of on set of the DHTR, the levels were still above normal, and a moderate in crease was observed, followed by a drop to normal levels in the course of
Inflammatory mediators and anti-inflammatory substances
During the observation period, IL-l was not detectable, while levels of IL lra exceeded 3000 pg per mL throughout. TNFa, IL-6, IL-8, and IL 10, as weil as PMN elastase and neopterin, were elevated at the time of diagnosis of DHTR, with peak val ues at the beginning of (TNFa, IL-lO) or during (IL-6, IL-I0) the exchange transfusion; this was followed bya de cline (Figs. 6-8 ). IL-6 and IL-lO in creased after nephrectomy, while a short-lived second peak in TNFa was observed during the seco nd ex change transfusion. IL-8 showed a second peak on Days 15 and 16. Neopterin levels increased sixfold from Day 10 to Day II-that is, at the 17
15
. . ..----.. . . 15 17 19 cance for the DHTR, as theywere first MT (2) Ni detected after the exchange transfu sion, in which the patient had re ceived RBCs that were negative for With column agglutination technol The protein measurements of complement compo ogy, traces of IgM were detectable before the exchange nents C3 and C4 showed a similar profile; the level was below or in the lower part ofthe nor mal range. An elevation in terms of an acute-phase response was not evi dent, and a decline occurred in the second phase of the exchange trans fusion (Fig. 9) . Cl inhibitor levels were just above or in the upper part of the normal range and otherwise followed the same profile as C3 and C4. C3a-desArg was elevated at the beginning of the exchange transfu sion and showed a peak toward the end, which correlated with a decline in the C3 protein (Fig. 9) . A further small peak was observed before the second exchange transfusion.
DISCUSSION
On Day 10, after a massive transfu sion ofD-positive blood to a D-nega tive patient, the appearance of clini cal symptoms coincided with a sharp rise in the titer of anti-D. It was not clear whether the patient had re ceived transfusions before; neverthe less, it is likely that he was immunized transfusion was initiated; it is unclear whether this finding 80 I_TNFaIlIL-6 hemolysis. The decision for an ex change transfusion was made on the is specific or whether it may be due to unspecific adsorp basis of an unstable circulatory and respiratory situation as tion of IgM to cells that are heavily loaded with IgG. With weil as a progressive impairment ofrenal function in a pa flow cytometry, no IgM was detectable; however, IgM with tient affected by heart and kidney disease. Of the inflammatory mediators and anti -inflammatory substances tested, mostwere elevated at the time the DHTR was diagnosed and showed peaks at the beginning or dur ing the exchange transfusion. Among these were the proinflammatory cytokines TNFa, lL-8, and lL-6, the anti inflammatory mediators lL-1O and lL-lra, elastase, and neopterin, a metabolic product of monocytes. The descrip tion of the pattern of mediators in this single, clinically com plicated case does not allow firm general conclusions about cause-and-effect relationships; nevertheless, it raises ques tions about pathophysiological mechanisms that may stim ulate further investigations.
300,---------,------------------------
TNFa is known to stimulate the release of other inflam matory cytokines. The injection of recombinantTNFa into humans causes the appearance ofIL-6 and lL-8 and an in crease in IL-lra, whereas lL-1 is not detectable." Further more, characteristic changes in theWBCcount are induced: lymphocytopenia, monocytopenia, and a biphasic behav ior of neutrophil counts, with an initial decrease followed by neutrophilia. TNFa also induces an increase of plasma elastase-u.-antltrypsin complexes, due to neutrophil acti vation, and is known as a pyrogen by direct action on the hypothalamus.l! Although detectable levels of the short lived cytokine TNFa appear to be low in the case reported here, there was a stepwise reduction during the exchange transfusion, and many of the properties characteristic of TNFa were found in conjunction with the DHTR: fever as the initial sign; peaks ofIL-6 and IL-8that are somewhat de layed with respect to the appearance of TNFa; high levels of lL-1ra in the absence of lL-1; and elevated levels of elastase, monocytopenia and lymphocytopenia and a biphasic change in theWBC count, wherebythe major part of theWBCswas represented by the neutrophils.lt is, there fore, tempting to speculate that TNFa, which may have been released much earlier than the monitoring showed, played a role in the inflammatory response that accompa nied the DHTR. Butler Like TNFa, IL-8 has proinflammatory properties; it functions as an activator and chemoattractant of neutro phils; and elevated levels are found in a number ofinflam matory disease states as weil as in trauma and sepsis.P" In the DHTR described here, the order of cytokines released was the same as that in the baboon model of endotox inemia": IL-8 appeared simultaneously with lL-6, but somewhat after the appearance of TNFa, which is known as an inducer of these two cytokines.
At the time of diagnosis of the DHTR described here, Ih-l ra was present in the absence of detectable lL-1. The
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absence ofIL-1, or the presence oflow levels, together with the presence of high levels of, is a common finding in pa tients with severe illness, sepsis, or trauma'<'? or after the injection of recombinant TNFa into humans.l" Only after the application of high doses of endotoxin into animals does IL-l appear.>' The question has been raised as to whether lL-1 is really absent or whether measurements are interfered with by Inhibitors.' The release ofIL-1ra is inter preted as a counterregulation of the proinflammatory stimuli ofIL-1; because 1L-1ra is a competitive inhibitor of lL-1 at the receptor level, relatively high amounts are re quired to counteract the function of Il.s l." In the course of the DHTR described here, the cytokine antagonist lL-1O also was present. lL-10 is a potent deactivator ofmonocytes and macrophages, and it inhibits the production of several proinflammatory cytokines, such as lL-1, TNFa, lL-6, and lL-8. 18 ,19 An early counterregulation may, on the one hand, be favorable by balancing an overreaction of inflammatory cytokines and thereby preventing damage; on the other hand, it has been reported that astate of immunosuppres sion, predisposing to infectious complications, is induced after hernorrhage, trauma, and sepsis." The presence of counterregulatory mediators in the case reported here raises the question of whether, after hemorrhage and DHTR, the repetitive infectious complications experienced bythe patient, the Iong-lasting lymphopenia, and the slow recovery were a reflection of astate of immune paralysis.
lL-6 is a major inductor of hepatic synthesis of acute phase proteins, and it is released after operation, trauma, sepsis and other states of SIRS. 4 ,16 In the study presented here, the levels of the acute-phase protein CRP showed a correlation with the levels of lL-6. Stimuli for the release of CRP seemed to be the massive transfusion, the onset of DHTR, and nephrectomy. Before the diagnosis of the DHTR, 1L-6levels were not available, but the onset of the DHTR and nephrectomy were both marked by an increase in IL-6. Fibrinogen showed, as expected, a slower response to the massive transfusion; only a small further augmenta tion was observed at the time of the DHTR, but the maxi mum of the peak was reached I day earlier than the peak of lL-6 and, hence, was not in obvious correlation to this cytokine. The coagulation disease and the exchange trans fusion in conjunction with the DHTR probably influenced the course of fibrinogen levels.
Elevated levels of C3a throughout the observation pe riod were an indicator of complement activation. Comple ment peptides are known to induce the release of TNFa, lL-1, lL-6, and lL-8 from WBCS.21-Z3 The main peak of C3a was not in correspondence to that of TNFa, and a correla tion to other cytokines remains speculative, because it may be assumed that the levels measured were influenced by the exchange transfusion. Antibodies of the Rh system are gen erally considered not to be cornplement-activating." The relatively slow hemolysis in the presence of a strongly posi tive DAT and the moderate decrease in C3, C4, and Cl inhibitor suggest that, in this DHTR, destruction of RBCs predominantly occurred in a slow process via the reticulo endothelial system.
It is weil known that hemolytic transfusion reactions may cause renal dysfunction, and several hypotheses have been put forward for the mechanisms bywhich this occurs," The profiles for urea and creatinine were similar in the DHTR described here, and they suggest that the DHTR caused an impairment of kidney function. But it may be assumed that the underlying disease of the patient favored this process. As expected, nephrectomy caused a second rise in these two measures.
The APACHE Ir score showed a peak with I to 2 days' delay over the appearance of the maximum levels of cytokines. Because of its complexity, the overall clinical pic ture may require time to develop in response to biologic modifiers.
The patient underwent hemorrhage and massive trans fusion 10 days before the DHTR. No data on the cytokine pattern are available from the time ofthe massive transfu sion until the onset ofthe DHTR, but it has been reported that, in the animal model, hemorrhage may cause the re lease of cytokines and a dampening of the immune re sponse." Because the WEC count, the platelet count, he moglobin, and the acute-phase proteins CRP and fibrinogen showed a tendency to normalize after the mas sive transfusion, it is not likely that the effects ascribed to the DHTR were solely due to this previous event, but a modulation ofthe mediator response, qualitatively and/ or quantitatively, is probable.
It may be assumed that the levels of the mediators, proteins, and fragments measured were influenced by the exchange transfusion, for example, by dilution effects, aug mentation of the inhibitory potential, and the supplying of unactivated proteins. It is difficult to evaluate whether the exchange transfusion by itself caused mediator release. In this case, the second exchange transfusion, which it can be seen retrospectively could have been omitted, should have reproduced the pattern of the first. Although a second short-lived peak ofTNFa appeared during the second ex change transfusion, the overall picture is not suggestive of a major release of mediators induced bythe exchange trans fusion.
D-incompatible transfusion, although potentially life threatening, is unavoidable in emergency situations such as the need for massive transfusion at the same time that there is a shortage of supplies. Except for the exchange transfusion, the present treatment regimens for the rarely developing DHTRs mainly address the symptoms. Despite major obstacles in the treatment of sepsis or SIRS caused by the complexity of interactions of multiple immunologic mediators, the recognition of hemolytic transfusion reac tions as a reflection ofSIRS may guide the development of future treatment strategies.
